UBS Lowers Oracle Price Target to $250

UBS analyst Karl Keirstead lowered the price target on Oracle (NYSE: ORCL) to $250.00 (from $280.00) while maintaining a Buy rating.

“Right ahead of a planned debt issuance, Oracle press-released some incremental disclosures about its funding needs in 2026, required to finance the build-out of AI infrastructure.

Oracle disclosed that it will raise $45-50 billion in cash in 2026 via a roughly equal balance of debt and equity and that it remains committed to its investment grade rating.

The planned debt raise of “only” $20-25 billion coupled with an equity raise of up to $20 billion will likely come as a relief to credit investors while the equity raise (which Oracle has long described as a last resort) may not be warmly received by all equity holders.

We are Buy-rated and wonder if this long-awaited clarity may serve as a clearing event for the stock.”

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.